GENEVA, July 27 -- HUGEL INC. filed a patent application (KR2026/000797) for “NOVEL ANTI-BOTULINUM TOXIN ANTIBODY”. With publication no. WO/2026/155534, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/1282
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....